In this study, using gene expression profiling of 24 cell lines from different cancer types and in a panel of ovarian cancer cell lines, we found that nuclear‐specific enrichment of checkpoint kinase 1 (CHK1) correlated with increased sensitivity to elimusertib. The gene discussed is CHEK1; the disease is ovarian cancer.